Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anwaar Saeed

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 20, 2020
Preoperative Screening of Colorectal Cancers Is As Accurate As Postoperative Screening for Detection of Lynch SyndromeJack Harrigan, Christian Davis, Mahak Chauhan, et al.
Medical Oncology (Northwood, London, England)|March 21, 2025
Efficacy and safety of KRAS -G12C inhibitors in colorectal cancer: a systematic review of clinical trialsMohamed Saad Sayed, Yassine Alami Idrissi, Owais Ahmed, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
A Meta-Analysis to Assess the Efficacy of HER2-Targeted Treatment Regimens in HER2-Positive Metastatic Colorectal Cancer (mCRC)Akshit Chitkara, Muhammad Bakhtiar, Ibrahim Halil Sahin, et al.
Cancer Treatment Reviews|January 13, 2025
Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: A systematic review and updated meta-analysisIsabella Michelon, Caio E R Castro, Thiago Madeira, et al.
Future Oncology (London, England)|July 23, 2024
STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancerAnwaar Saeed, Josep Tabernero, Aparna Parikh, et al.
Cancers|July 12, 2025
The Role of ENHO in Pancreatic Adenocarcinoma: A Bioinformatics ApproachOsama M Younis, Zeid K Al-Sharif, Ahmad E Saeed, et al.
Journal of Surgical Oncology|July 31, 2025
Optimizing Perioperative Management of Pancreatic Ductal Adenocarcinoma: Insights Into Modified FOLFIRINOX Relative Dose Intensity and CA 19-9 DynamicsJiage Qian, Nikhil V Tirukkovalur, Janie Y Zhang, et al.
Journal of Oncology|June 13, 2019
Clinical Outcome of Ampullary Carcinoma: Single Cancer Center ExperienceMohammed Al-Jumayli, Amna Batool, Akshay Middiniti, et al.
Technology in Cancer Research & Treatment|November 14, 2024
The Prognostic Significance of NEDD9 Expression in Human Cancers: A Systematic Review, Meta-Analysis, and Omics ExplorationJehad A Yasin, Ramez M Odat, Fares A Qtaishat, et al.
Future Oncology (London, England)|June 25, 2026
EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual diseaseAnwaar Saeed, Greg Yothers, Shannon L Puhalla, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 20, 2020
Preoperative Screening of Colorectal Cancers Is As Accurate As Postoperative Screening for Detection of Lynch SyndromeJack Harrigan, Christian Davis, Mahak Chauhan, et al.
Medical Oncology (Northwood, London, England)|March 21, 2025
Efficacy and safety of KRAS -G12C inhibitors in colorectal cancer: a systematic review of clinical trialsMohamed Saad Sayed, Yassine Alami Idrissi, Owais Ahmed, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
A Meta-Analysis to Assess the Efficacy of HER2-Targeted Treatment Regimens in HER2-Positive Metastatic Colorectal Cancer (mCRC)Akshit Chitkara, Muhammad Bakhtiar, Ibrahim Halil Sahin, et al.
Cancer Treatment Reviews|January 13, 2025
Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: A systematic review and updated meta-analysisIsabella Michelon, Caio E R Castro, Thiago Madeira, et al.
Future Oncology (London, England)|July 23, 2024
STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancerAnwaar Saeed, Josep Tabernero, Aparna Parikh, et al.
Cancers|July 12, 2025
The Role of ENHO in Pancreatic Adenocarcinoma: A Bioinformatics ApproachOsama M Younis, Zeid K Al-Sharif, Ahmad E Saeed, et al.
Journal of Surgical Oncology|July 31, 2025
Optimizing Perioperative Management of Pancreatic Ductal Adenocarcinoma: Insights Into Modified FOLFIRINOX Relative Dose Intensity and CA 19-9 DynamicsJiage Qian, Nikhil V Tirukkovalur, Janie Y Zhang, et al.
Journal of Oncology|June 13, 2019
Clinical Outcome of Ampullary Carcinoma: Single Cancer Center ExperienceMohammed Al-Jumayli, Amna Batool, Akshay Middiniti, et al.
Technology in Cancer Research & Treatment|November 14, 2024
The Prognostic Significance of NEDD9 Expression in Human Cancers: A Systematic Review, Meta-Analysis, and Omics ExplorationJehad A Yasin, Ramez M Odat, Fares A Qtaishat, et al.
Future Oncology (London, England)|June 25, 2026
EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual diseaseAnwaar Saeed, Greg Yothers, Shannon L Puhalla, et al.
Pageof 17